Clinical and Biochemical Influence of Prostatic Stones

Autor: Tomislav Sorić, Jerka Dumić, Lada Bakovic, Robert Selthofer, Mirnes Selimovic, Tatjana Šimurina
Rok vydání: 2016
Předmět:
Adult
Male
medicine.medical_specialty
Urology
Interleukin-1beta
030232 urology & nephrology
Prostatitis
Sensitivity and Specificity
Severity of Illness Index
Calculi
03 medical and health sciences
0302 clinical medicine
Lower Urinary Tract Symptoms
Lower urinary tract symptoms
Prostate
Semen
Surveys and Questionnaires
Severity of illness
medicine
Cytokines · Inflammation · Lower urinary tract symptoms · Prostate · Prostate stones
Humans
Prospective Studies
Prospective cohort study
Inflammation
business.industry
Tumor Necrosis Factor-alpha
Interleukin-8
Prostatic Stone
Middle Aged
Prostate-Specific Antigen
medicine.disease
Prostate-specific antigen
medicine.anatomical_structure
ROC Curve
030220 oncology & carcinogenesis
Quality of Life
Cytokines
International Prostate Symptom Score
business
Rheology
Biomarkers
Zdroj: Urologia internationalis. 98(4)
ISSN: 1423-0399
Popis: Introduction: The study aimed to explore clinical influence of prostatic stones on lower urinary tract symptoms (LUTS), seminal plasma cytokines, and serum biomarkers. Materials and Methods: A total of 70 men aged ≤50 years with LUTS divided into 2 groups: group with stones (GSt) and group without prostatic stones (GNoSt). All subjects completed the International Prostate Symptom Score (IPSS) questionnaire and National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) scoring questionnaire. Pre- and post-prostate massage test and uroflowmetry were performed. The serum concentration of total prostate specific antigen (PSA), free PSA, and free/total PSA (f/t PSA) ratio, seminal concentration of cytokines interleukin (IL)-1β, IL-6, IL-8, IL-10, IL-12p70, and tumor necrosis factor-alpha were measured. Results: GSt subjects had significantly more severe symptoms based on IPSS answers (p = 0.0289). All domains in NIH-CPSI scores were significantly higher in the GSt group: pain (p = 0.001), urinary symptoms (p = 0.023), quality of life (p = 0.008), and with overall (p = 0.003). GSt subjects also had significantly lower maximum urinary flow (Qmax; p = 0.011), lower f/t PSA ratio (p = 0.048), and higher concentration of IL-1β (p = 0.011) and IL-8 (p = 0.001). Conclusions: Prostatic stones may influence the severity of LUTS and the symptoms of chronic prostatitis. They might reduce Qmax rate and lead to reduction of the f/t PSA ratio and produce more severe inflammation causing increased seminal concentration of IL-1β and IL-8.
Databáze: OpenAIRE